+86-27-65522453 sales@sun-shinechem.com

AT13148

Catalog No.: 51902
Cas No.: 1056901-62-2
Purity : 98%;ee>98% 
51902 - AT13148 | CAS 1056901-62-2

Catalog number : 51902

CAS number : 1056901-62-2

分子式 : C17H16ClN3O 

分子量 : 313.78 

Iupac 化学名称 : (S)-1-(4-(1H-pyrazol-4-yl)phenyl)-2-amino-1-(4-chlorophenyl)ethanol 

Smile : ClC1=CC=C([C@](C2=CC=C(C3=CNN=C3)C=C2)(O)CN)C=C1

InChiKey : IIRWNGPLJQXWFJ-KRWDZBQOSA-N

PackagingPriceAvailabilityPurityEstimated Shipping Time
BulkEnquiryEnquiry
Request Bulk Quote Download MSDS电话:+86-27-59253327 | Email:sales@sun-shinechem.com
同义词AT13148;AT-13148 
英文同义词AT13148;AT-13148 
分子式C17H16ClN3O 
分子量313.78 
外观off-white solid 
纯度98%;ee>98% 
可溶性5mg/ml in DMSO 
存储3 years -20ºCpowder 6 months-80ºCin solvent 
运输条件Shipped under ambient temperature. 
SmileClC1=CC=C([C@](C2=CC=C(C3=CNN=C3)C=C2)(O)CN)C=C1
InChiKeyIIRWNGPLJQXWFJ-KRWDZBQOSA-N
InChiInChI=1S/C17H16ClN3O/c18-16-7-5-15(6-8-16)17(22,11-19)14-3-1-12(2-4-14)13-9-20-21-10-13/h1-10,22H,11,19H2,(H,20,21)/t17-/m0/s1
Coming soon.

AT13148, a first-in-class multi-AGC kinase inhibitor, against gastric cancer cells. AT13148 exerted potent cytotoxic and anti-proliferative activities against a panel human gastric cancer cell lines (HGC-27, AGS, SNU-601, N87 and MKN-28), possibly via inducing cancer cell apoptotic death. Apoptosis inhibition by the Caspase blockers dramatically attenuated AT13148-caused cytotoxicity against gastric cancer cells. Intriguingly, same AT13148 treatment was not cytotoxic/pro-apoptotic to the non-cancerous human gastric epithelial GEC-1 cells. At the signaling level, AT13148 treatment in gastric cancer cells dramatically suppressed activation of multiple AGC kinases, including Akt (at p-Thr-308), p70S6 kinase (p70S6K), glycogen synthase kinase 3 (GSK-3) and p90 ribosomal S6 kinase (RSK). Our in vivo studies demonstrated that daily oral gavage of AT13148 at well-tolerated doses significantly inhibited HGC27 xenograft tumor growth in nude mice. AGC activity was also dramatically decreased in AT13148-administrated HGC27 tumors. Therefore, targeting AGC kinases by AT13148 demonstrates superior anti-gastric cancer activity both in vitro and in vivo. The preclinical results of this study support the progression of this molecule into future evaluation as a valuable anti-gastric cancer candidate.

 

1056901-62-2 - Request Bulk Quote

×
1056901-62-2 - Request Bulk Quote
Change